13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001892688-23-000073
Total Value
$152.6M
Positions
18
Other Managers
1
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 1,152,525 | $30.3M | 19.88% |
| 2 | CABALETTA BIO INC | CABA | 2,181,377 | $28.2M | 18.45% |
| 3 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,670,472 | $27.5M | 17.99% |
| 4 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,205,050 | $13.2M | 8.65% |
| 5 | TSCAN THERAPEUTICS INC | TCRX | 5,224,600 | $13.1M | 8.56% |
| 6 | GH RESEARCH PLC | GHRS | 969,374 | $11.5M | 7.54% |
| 7 | PARDES BIOSCIENCES INC | 69945Q105 | 3,902,434 | $7.1M | 4.63% |
| 8 | THESEUS PHARMACEUTICALS INC | 88369M101 | 757,009 | $7.1M | 4.63% |
| 9 | KINNATE BIOPHARMA INC | 49705R105 | 2,048,736 | $6.2M | 4.07% |
| 10 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 3,094,554 | $2.6M | 1.68% |
| 11 | PIERIS PHARMACEUTICALS INC | 720795103 | 9,775,849 | $1.6M | 1.06% |
| 12 | CULLINAN ONCOLOGY INC | CGEM | 115,063 | $1.2M | 0.81% |
| 13 | PASSAGE BIO INC | PASG | 1,167,343 | $1.1M | 0.72% |
| 14 | STRUCTURE THERAPEUTICS INC | GPCR | 23,000 | $956,110 | 0.63% |
| 15 | ATHIRA PHARMA INC | 04746L104 | 193,573 | $571,040 | 0.37% |
| 16 | PHARVARIS N V | PHVS | 21,225 | $321,347 | 0.21% |
| 17 | COMPASS PATHWAYS PLC | CMPS | 20,114 | $166,544 | 0.11% |
| 18 | DBV TECHNOLOGIES S A | DBVTF | 18,265 | $34,704 | 0.02% |